Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Nov 16, 2013; 5(11): 574-580
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.574
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.574
Pre-EUS indicators |
Indications for procedure |
Detailed description of the patient by the referring physician |
Patient completed procedural preparation of minimum 6 h NPO |
Antibiotics per protocol were given in the need to perform FNA of pancreatic cysts |
Listing of sedatives administered prior to and during EUS |
Patient signed agreement of informed consent for EUS and/or if consented for research study |
Intra-procedural indicators |
A detailed description of the methods used to visualize routinely evaluated EUS organs. If there is any suspicion of organ pathology, the respective organ parenchyma should be described: |
Suspected pancreatic lesions should include a parenchymal description including the body, head, tail, and duct |
Common bile ducts and gallbladder contents should be detailed and a description of the biliary tree for sludge, stones, or other findings |
If found, prominent lymph nodes should be described in detail as well as the kidneys and left liver lobe for the presence or absence of lesions |
The celiac axis should be described for general arterial structure along with the aorta and superior mesenteric artery as well as the presence or absence of identifiable lymph nodes |
Description of abnormal/pathological results: |
Description of any tumor by the tumor, node, and metastasis system |
Accurate detailing of the lesions and its surroundings in accordance with layers visualized by EUS |
Degree of tumor penetration into organ mucosa and surrounding structures |
Detailing the presence of lymph nodes when suspicious for malignancy and when performing FNA |
Intra-procedural issues |
Presence or absence of any mechanical problems or difficulties including past abdominal surgeries or ascites |
Patient awakened/uncooperative during the procedure |
Details of the number of FNAs performed with respective number of passes into each suspected lesion including: |
Number of passes |
Needle size |
Number of needles |
Impressions of aspirate (bloody, mucinous, color, etc.) |
Cytology and/or histological examination |
In-room tentative diagnosis |
Post-procedural indicators |
Summary of medical diagnoses |
Examination findings, even if not relevant to the reason for EUS referral, should be listed |
Physician recommendations shall be listed with respect to examination findings including instructions for the patient |
Instructions for how patients will receive the results and for referring physician |
After EUS, the incidence of adverse events should be listed, including pancreatitis, bleeding, and/or infections and the need for hospitalization |
- Citation: Lachter J, Bluen B, Waxman I, Bellan W. Establishing a quality indicator format for endoscopic ultrasound. World J Gastrointest Endosc 2013; 5(11): 574-580
- URL: https://www.wjgnet.com/1948-5190/full/v5/i11/574.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i11.574